🎁 Black Friday: up to 50% off of annual plans
Coromandel International Limited (NSE:COROMANDEL)
India flag India · Delayed Price · Currency is INR
1,996.00
+24.00 (1.22%)
Nov 20, 2026, 3:28 PM IST
← View all transcripts

Q2 26/27

Nov 12, 2026

Summary

Q2 revenue rose 6%, but EBITDA fell 18% amid weak fertilizer demand and input-cost pressure. Revised Rabi subsidies, moderating costs and stronger retail, crop-protection and specialty businesses support cautious H2 optimism.

Operator

Ladies and gentlemen, good day and welcome to the Coromandel International Limited Q2 and H1 FY 2027 earnings conference call hosted by Systematix Shares and Stocks Limited. As a reminder, all participant lines will be in the listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during the conference call, please signal for an operator by pressing star and zero on a touch-tone phone. I now hand the conference over to Mr. Harmish Desai. Thank you, and over to you, sir.

Harmish Desai
Analyst, Systematix Shares and Stocks Limited

Thank you, Shaurya. Good morning and welcome to the Q2 and H1 FY 2027 earnings call of Coromandel International Limited, hosted by Systematix Institutional Desk. From the management, we have Mr. S. Sankarasubramanian, Managing Director and CEO, Mr. Deepak Natarajan, Chief Financial Officer. I would like to thank the management for giving us the opportunity to host this call. We will begin the call with opening remarks from Mr. S. Sankarasubramanian, followed by Mr. Deepak Natarajan for update on financial performance, post which we will have a Q&A session. Thank you, and over to you, sir.

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

Thank you, Harmish, for organizing the call. Good morning, everyone. I hope you had a wonderful Diwali. My belated wishes to you and to your family. I will begin with an overview of brief business environment experience during the quarter and also provide an update on operational performance. Then I will request Deepak to take us through the financial performance. As you all know, Q2 was an unprecedentedly challenging quarter for the industry. We had multiple headwinds coming together at the same time. Deficit rainfall in key markets, rupee depreciation, elevated raw material prices, lower NBS rates, and weak consumption impacted the operating environment.

In fact, rainfall deficit was around 20%-30% in our key markets such as Andhra Pradesh, Telangana, Karnataka, Maharashtra, and this has impacted the agricultural activity as well as input consumption. Also, the widening price differential between DAP and complex fertilizers influenced the farmer buying behavior and impacted the offtake of NPKs. All these factors resulted in soft industry-wide decline in fertilizer volume, with production and consumption of NPKs has fallen considerably by 40% during this quarter. Happy to note that government yesterday announced the NBS rate for Rabi 2026-2027 season.

This is a very timely and positive intervention, particularly given the fact that there has been significant volatility in international fertilizer and raw material markets. This improved subsidy support should help improving the viability of domestic manufacturing and restore better pricing balance between DAP and complex fertilizers, thereby supporting the adoption of balanced nutrition. We are still awaiting detailed notification, and the revised rates appear to align with the NBS mechanism, which is underlying principle of reflecting the movements in international raw material and fertilizer prices.

The government has also announced a special support to address the exceptional increase in sulfur and sulfuric acid prices, which has significantly impacted the cost of phosphatic fertilizers. During the year, government launched the Framework for Fertilizer Sale system on a pilot basis across select districts. These initiatives are very positive from the perspective of improving transparency and promoting efficient fertilizer usage. The initial implementation has also highlighted certain practical challenges, including longer purchase process for farmers, access to digital infrastructure, and accommodating farmer choice and brand preferences.

Industry has shared its feedback with the Department of Fertilizers, and we are hopeful that these operational aspects will be suitably addressed before the framework becomes a reality. In AgChem, we continue to see regulatory tightening, including restriction around certain molecules like carbosulfan and paraquat. However, Coromandel is expected to impact is not much. With respect to non-subsidy businesses, restriction has been imposed by certain states on the sale of non-subsidy fertilizers by fertilizer marketers. Industry has been engaging with the authorities in the state of U.P., Bihar, and Maharashtra, and we are hopeful that an appropriate framework can be evolved that protects farmer interests while continuing to encourage balanced nutrition and innovation.

During the quarter, Andhra Pradesh has announced a major program to develop Rayalaseema as a global horticulture and food processing hub, and significant expansion is planned in horticulture acreage. Given our strong presence in the region, our expected new granulation plant coming on stream in the near future, this augurs very well for Coromandel, and we see this as a positive long-term opportunity across our various segments, nutrients, crop protection, specialty nutrients, especially through our retail platform. Coming specifically to Q2 performance, as I mentioned, it was a very challenging quarter.

We sharpened our focus on differentiated offerings. We launched 10 new products across nutrients and crop protection segments. Reasonably, we managed the working capital well. Revenue grew by 6% to INR 10,348 crore, but however, EBITDA declined 18%, mainly due to compression in NPK fertilizer margins during this quarter. Also due to deficit in key markets on rainfall and higher input prices not adequately compensated by Kharif NBS rates, our performance across the value chain got impacted. In the fertilizer business, volume uptake was impacted due to monsoon price differentials.

However, we tried to increase our market share from 17%- 19%, and our primary sale for the quarter was down significantly by 30% to 10 lakh tons, and consumption also declined 33%. It's a conscious call taken by the company to moderate the primary sale and production and manage the working capital well, and tracking the consumption, the production, and supplies are moderated. The government announcing the new NBS rates for the Rabi season, we do expect that part of the benefits will be passed on in correcting the MRPs, which can revive consumption during the Rabi season.

The production got moderated by 15% in Q2 to 7.7 lakh tons due to softer demand. Our newly commissioned phosphoric acid and sulfuric acid plant at Kakinada has come at a right time to ensure availability of these key raw materials, even though we operated the plant at a lower capacity until we got the sulfur subsidy notification sometime in August. With sulfur subsidy coming in, this new project is back on track and started operating at full capacity.

This will support the value creation in a highly volatile operating environment. Thanks to the timely government intervention. Our granulation plant project is progressing well in Kakinada. We hope to commission this by February of this year. This capacity should be available for the next year. Overall, we can see a moderation in the global raw material prices. While urea has come off some time back, we have seen softening approach in sulfur as well. Sulfur is now likely to go below $900 due to stiff resistance from metal segment as well as in the fertilizer segment. I do expect sulfur used to be a disposal problem.

This can become an opportunity to bring it down below $500 as well if we sustain our approach in terms of smart purchases. DAP continue to remain more or less at the same level in the last two months. Phosphoric prices have been rolled over at $1,700 as sulfur prices remained high during this period. SSP volumes again got moderated by 13% to 1.9 lakh tons. Our focus on differentiated grades in terms of GroPlus and Urea SSP has been quite helpful and helped us to improve the contribution and margins. Moving on to Crop Protection segment. Crop Protection demand remains soft during the quarter. The impact of rainfall has had a cascading effect on the agrochemicals as well.

The exports demand recovery has been gradual as farm economics was impacted due to high fertilizer costs and relatively docile agri prices. Encouragingly, we are seeing improvement in the price of certain agriculture commodities globally. That should improve the offtake of agri ingredients as well. Crop Protection business delivered 22% revenue growth during the quarter, supported by strong performance in export market. Our diversified global presence continue to provide opportunities to deepen our presence across key geographies. Domestic market, we continue to invest in portfolio development and differentiated offerings, with new products contributing 36% during the year.

During the quarter, we introduced six new products across agrochemicals and biologicals. There has been some impact on margin for few molecules, but it broadly remains at comfortable level given the variability in crude intermediates experience in H1. Customers have deferred the purchases. This had a bearing on the production of product offtake as well. We are expanding the capacity of one of our key molecules that will come on stream by this month end. We are also planning to establish fluoro launch plant at Ankleshwar, as we strongly believe fluorination chemistry is going to be the next major intervention in agrochemicals value chain.

After successful trial runs of launch plant, hopefully it should pave the way for the ultimate commercial project for the specialty chemicals, which we envisaged two years before. On the subsidy NACL, there we have seen the numbers. Revenues are at INR 374 crore, down 18%, and EBITDA at INR 12 crore, significantly lower than corresponding quarter of the last year. It is a one-off operation the company witnessed due to significant margin pressure after carryover high-cost inventory. The corresponding pass-on could not happen due to market compression. Prices of certain key molecules came down. The company has to take a significant impact on the margins.

Lot of initiatives are taken up to have a synergistic approach between Crop Protection business of Coromandel and NACL in terms of portfolio, in terms of sourcing strategies, optimizing the production capacities, leveraging on the product portfolio capabilities. Lot of initiatives are underway, and hope to see a robust comeback of NACL performance in the coming quarters. Our retail business had a very strong quarter, supported by continued focus on farmer engagement and crop-specific campaigns across markets. We are seeing good traction on our proprietary product portfolio. Some of our retail white label brands scaling up well and expected to cross INR 100 crore in annual sales this year.

We also continue to expand our physical reach, adding 80 stores during Q2 and taking the overall network to 1,300 stores across Andhra Pradesh, Telangana, Karnataka, Tamil Nadu, Maharashtra. Retail is an untold story. It's been playing out very well for us. The team has done an extraordinary job in terms of stressful monsoon situation. They provided alternate products, organic fertilizers, specialty nutrients, which helped them to achieve the bottom line. Some of the new stores have reached the break-even much faster than what we initially expected.

New stores have started contributing meaningfully, reinforcing our confidence in scalability of the models, and we are on our journey to enhance the network to 2,000 stores over the next two years. As specialty nutrients, organic and biological business also performed well. In this stressful situation, the adoption of water solubles and the specialties are gaining traction, and Coromandel is rightfully positioned in terms of making these product offerings differentiated solution to the farmers. It is more relevant during this water stress conditions and the growing emphasis on sustainable agriculture.

Overall, I think with the better policy support through the revised NBS rates, improved farm economics, moderating in the input costs, and the seasonal pickup in Rabi activity, I do expect operating environment is going to be much better H2 with improved bounce back on the production, sales, consumption. Of course, I'm cautiously optimistic at this point of time, and I'm sure if El Niño predictions are coming true, by year-end, El Niño could move to the neutral position, which provides very optimism for the forthcoming Kharif season as well. Now, I would request Deepak to talk about the financial performance.

Deepak Natarajan
CFO, Coromandel International

Thank you, Sankar. Good morning, all. Diwali greetings and Deepavali greetings to all. The company recorded a consolidated total income of INR 10,348 crore during the quarter, compared to INR 9,771 crore in Q2 of last year, registering a growth of 6%. The revenue increase has been mainly on account of higher subsidy rates versus last year and growth across the various businesses. It is pertinent to note that last year Q2 results includes NACL numbers effective August 8th, 2025 onwards. Overall, the subsidy share of the business stands at 81% during the quarter, which compares with 83% in the last year.

As far as profitability is concerned, the company reported a consolidated EBITDA for the quarter of INR 944 crore as against INR 1,147 crore last year, registering a degrowth of 18%. The decrease in EBITDA is mainly due to higher input prices on account of ongoing Middle East crisis and not commensurate with some of the revisions in the NBS rates and the retail prices, MRP. The profitability share of subsidy business stands at 58% compared to 72% last year. Net profit after tax for the quarter was INR 523 crore in comparison to INR 793 crore last year. Moving on to the financial performance of the first half of the year, the company recorded a consolidated total income of INR 18,563 crore during H1 versus INR 16,897 crore in H1 of last year, registering a growth of 10%.

The subsidy share of the business stands at 79% compared to 83% last year. With regard to profitability in H1, the consolidated EBITDA was reported at INR 1,705 crore against INR 1,929 crore last year, registering a degrowth of 12%. The profitability share of the subsidy business stands at 53% compared to 70% last year. The net profit after tax for H1 was INR 905 crore compared to INR 1,295 crore in the previous year. As far as subsidy is concerned, during the quarter, company received INR 3,086 crore towards subsidy claims.

Government has been prompt in clearing all the subsidy dues. As of today, we have received subsidy claims till the September fourth week. In October, the company further received subsidy of about INR 1,200 crore. During H1, the company has received INR 4,478 crore towards subsidy claims. The subsidy outstanding as of September was INR 3,535 crore compared to INR 3,199 crore in the previous year. With regard to forex, during the Q2, rupee traded in a range of about INR 94.5-INR 96.6. Coromandel continues to hedge its exposure on a conservative basis. Thank you. With that, I hand it over to Harmish.

Operator

Thank you very much. We will now begin with the question- and- answer session. Anyone who wishes to ask a question may press star and one on their touchtone telephone. If you wish to remove yourself from the question queue, you may press star and two. Participants are requested to use handsets while asking a question. Ladies and gentlemen, we will wait for a moment while the question queue assembles. The first question is from the line of Prashant Biyani from Elara Securities Private Limited. Please go ahead.

Prashant Biyani
Analyst, Elara Securities Private Limited

Thank you for the opportunity and Diwali greetings to the management. Sir, what kind of MRP reduction is expected, maybe gradually or at once, after the subsidy increase?

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

It is very difficult to put the number. We need to get the specific notification and then we will respond. But at least I feel NP grades, like 20:20, which has seen a very sharp increase from INR 1,350 per bag to INR 2,100, there we expect moderation to happen. It can be minimum 10%-15% of moderation is possible in those fertilizers. But let us not forget the fact that companies were incurring huge negative margins. This subsidy will partially offset that, and if still there is a scope, we may be able to do this MRP correction. Because again, ammonia started spiking, so we need to wait and see. Definitely, we will look for some moderation in prices, because it is not sustainable to continue to have wider gap with the DAP.

Prashant Biyani
Analyst, Elara Securities Private Limited

Sure. Sir, how much of sulfur subsidy have we considered in our Q2 results?

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

You know the notification clearly says subsidy is applicable to the floor price of $800.

Prashant Biyani
Analyst, Elara Securities Private Limited

Yeah.

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

So when sulfur went up, we decided to curtail our purchases. Whatever shipments we have got beyond this price threshold level, they are only eligible for the subsidy. It is not very significant, but has been quite helpful, especially for August and September. It would be difficult for me to put the number, but it came handy, especially for our Kakinada new plant. Our production was moderated, and after the sulfur subsidy announcement, we could get back on track.

Prashant Biyani
Analyst, Elara Securities Private Limited

Sure. And just lastly, sir, along with the Rabi subsidy notification, has this also been approved by cabinet or it is yet to be approved by them?

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

No, yesterday is the cabinet approval. There is no further approval required. It is all finally approved and cleared.

Prashant Biyani
Analyst, Elara Securities Private Limited

Even for sulfur?

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

Fine.

Prashant Biyani
Analyst, Elara Securities Private Limited

Okay. Thank you, sir.

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

Thank you.

Operator

Thank you. The next question is from the line of Riju from Antique Stock Broking Private Limited. Please go ahead.

Riju Dalui
Analyst, Antique Stock Broking Private Limited

Hi, sir. Thanks for the opportunity. My first question is regarding the non-subsidy business EBITDA. If you look at the subsidy business EBITDA, that was very much lower compared to last year, but the non-subsidy business EBITDA has seen a sharp jump in the H1 as well as in the 2Q. What explained that, if you could give some sense on this?

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

The non-subsidy business, the major share comes from crop protection business, where one of the molecules we had a challenge because of the carryover inventory, what I spoke about on NACL. Sulfur-based derivatives, which influences the input cost, but globally, there has been correction in the market price. Whereas initially in the first quarter, the prices all went up, but naturally, the global agricultural prices have remained soft for major portion of Q2. Hence, the uptake for price increase was not there. There is a high-cost input cost, not adequately compensated, and the moderation prices have happened.

That has compressed the margin. But lot of corrective actions have happened in terms of input price correction. We have moderated the inventory, and we are getting back on track. But the rest of the businesses, whether it is bioproducts or retail or specialty nutrients or SSP, they all done well. Another major reason, which is an aberration for this quarter, the ban on fertilizer companies doing sale of subsidized, non-subsidized product, especially in these key states of Maharashtra, Bihar, and U.P., has impacted the business. Hopefully, if that resolution comes back, we should come back on track. I think it is a temporary aberration. It should get restored.

Riju Dalui
Analyst, Antique Stock Broking Private Limited

Understood, sir. In the crop protection business, if you could provide the number for the standalone CPC business EBITDA margin, a broad indication.

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

CPC standalone is 16% for the current quarter. The off-year is 17%.

Riju Dalui
Analyst, Antique Stock Broking Private Limited

Okay. Understood. Sir, in the fertilizer business, if you look at in terms of the H1 or the 2Q performance for the industry, the DAP volume was, sales volume was flattish, while the NPK sales volume declined about 36%-38% on a YoY basis. Is this explained mainly because of the higher prices NPKs, or was there any cause of the crop-wise shifts that we have seen in the Kharif season?

First this, and second, looking at the subsidy, there is a high probability that industry-wise price cut might happen, and with that also, we might be able to maintain our margin profile. With that, can we expect the leftover inventory from Kharif will get cleared? How do you see the overall industry channel inventory situation for the 2H of this year, and how will be the impact overall for the DAP and NPKs inventory?

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

The NPK switch DAP has happened mainly because of artificially DAP prices pegged at INR 1,350, whereas the NP fertilizers like 20:20, the price went up to INR 2100. In a stressful situation, farmer never wanted to pay this sort of a price increase. Naturally, there has been a demand contraction, and farmers were looking for cheaper alternative DAP, which is a high-P product. This has been one of the major setback for the domestic manufacturers, and that is when government intervened and announced this sulfur subsidy, and then now they have corrected the Rabi rates to reflect the market reality. Up to INR 1,500 or INR 1,800 per bag of 20:20, the demand contraction was not happening. Once it was going beyond that, we could see demand contraction.

With the announcement of NBS rates, I think NP/NPK volumes will come back, and that will also reduce the import of DAP to a greater extent. I think what it used to be 60/40 between NPK and DAP turned out to be 30/70, 30% for NPKs and 70% for DAP. That is getting set right with the new NBS announcement. In terms of the channel stock, I would say it is not very high because industry has cut down the production, cut down the imports, anticipating demand contraction due to bad El Niño season. Thanks to that, the channel inventory buildup is not quite significant. There can be a marginal 5%-7% higher levels compared to last year. But with the next two, three months, industry will continue to moderate these inventories. Consumption will pick up with correction in MRP.

I think we should see reduced inventory levels as we close this year end. I don't see major challenge, and the system will can absorb this additional volumes which has been placed in Kharif that should get consumed now. Because outlook of Rabi is also depending on northeast monsoon, we are seeing two cyclones, and that has revived the prospects of chili crops in South, in Andhra market. Also in the North, it's early stage of Rabi. Wheat cropping is likely to be normal.

There can be impact on oilseeds and pulses. But overall, eastern region potato crop has come up well, and we also expect central region to pick up on volumes and crop acreages. I think there won't be any major deviation on consumption in the Rabi season, and with a reasonable level of inventory and the new NBS rates and the moderation prices, I do expect the consumption revival to happen, and we may end up with moderate inventory as we close this Rabi season by March.

Riju Dalui
Analyst, Antique Stock Broking Private Limited

Understood, sir. Thanks for the clarification, sir. One last bookkeeping question. What is the closing What is the inventory that we are holding as on September, and out of which, how much was at the dealer level and how much was at the factory level, if you could mention?

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

I'll get back to you specifically. I don't put out these numbers. There isn't a Nothing extraordinary, I would say, at this point of time. It's more or less getting maintained to the last year level as far as channel inventory is concerned. As far as factory production is concerned, we have curtailed our production considerably, as I mentioned in my note. We don't carry much of inventory in our plants and warehouses.

Riju Dalui
Analyst, Antique Stock Broking Private Limited

Understood. Yeah. Okay. Thanks for the clarification. Thank you.

Operator

Thank you. The next question is from the line of Darshita Shah from DSP Asset Managers. Please go ahead.

Darshita Shah
Analyst, DSP Asset Managers

Hi. Thank you. Firstly, with the sulfur subsidy coming through, Sankar sir, how are you seeing the backward integration spreads? Are they better than last year? Are they the same, especially given that the proportion of backward integration versus last year has now moved up? Should we see backward integration spreads improving maybe for the second half of the year?

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

Absolutely. In fact, from August onwards, we are back on track. Sulfur prices were ruling high, and we were not operating PA plant at full capacity. Never been the case so far for Coromandel. Now we are back on track, and from October onwards, we should scale up our volumes, and the value gap also has improved considerably. I think this improved impact on the overall performance from the value gap should kick in in second half.

Darshita Shah
Analyst, DSP Asset Managers

Hmm. All right. Are the spreads similar to, would it be anywhere in the range of $300-$350? Is that a safe assumption to make, or could it be higher or lower than that?

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

I think it's a safe assumption to make.

Darshita Shah
Analyst, DSP Asset Managers

Okay, great. Secondly, sir, when we look at Crop Protection EBIT, that is down about 20-odd% but our non-subsidy piece has done significantly well. You mentioned that it is because of the specialty nutrient and the other businesses that we have. Is this more of a proportion of the retail business being able to sell it better, or are we doing something differently to grow these brands, firstly? Secondly, is there any aberration because of lower NPK sales or lower DAP availability that the demand for these organic fertilizers have gone up? I mean, how should we be thinking about it, especially the non-subsidy, non-CPC part of the business?

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

No, you're absolutely right. It's a combination of factors, what you've rightly alluded to. Retail has got its act right in terms of positioning the right product depending on the market situation, and that was quite helpful. Also, we improved our network in Andhra, Telangana. That has also aided. In fact, most of the retail stores have improved the performance in a very short period of time. Also, when the NPK prices went up, the farmer tendency is to look for an alternate cheaper fertilizers, and organic fertilizers volumes have also picked up. Also, in the stressful condition, the natural tendency is to use more of water solubles and specialties.

So combination of multiple things, our retail connect, additional reach, and the scaling up of organic fertilizers. Globally, we are able to get the volume back. Ability to source neem at a competitive price, all this has been helpful in achieving non-CPC, non-subsidy products. It's increased network, improved product, and new product offerings also helpful. We launched two new products in organic fertilizers, which was received very well in the market. Some of the white label products which retail was doing, we are able to source it internally from our own bio business division that has scaled up well. Some of these products are reaching the size and scale of INR 100 crore brand. That was quite helpful.

Darshita Shah
Analyst, DSP Asset Managers

Okay. Thirdly, on the nano product, is it that we are seeing increased demand because of higher NPK prices? How should we be thinking about the overall contribution for the nano piece on revenue as well as on EBITDA?

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

See, nano has got a promising future. At least our experience has been extremely bullish on nano, not only in the domestic market, but also in the global markets. Unfortunately, the ban on this non-fertilizer in certain states has dampened the volumes. Key markets like U.P., Maharashtra, we had a setback, and we didn't position these materials during this quarter. Ideally, this should have picked up, and government has been promoting alternate to chemical fertilizers. These products should definitely be on the top. But unfortunately, this state ban has impacted the sale of nano. But I think that's a temporary challenge. We should come back on track on this.

Adoption has been very good. Whoever has bought last season, we are able to supply them nano this season as well. We have become a market leader on nano DAP. In fact, lot of new customers are coming. Globally also, we have started exporting certain consignments. We are in the process of registering this product in Latin American markets and Middle East and South Asian countries. Hopefully, we should see traction on nano volumes as well.

But it is very critical for us to remove this ban in these key states where the adoption can be higher, which we are working on. Otherwise, I think it's a promising product with a significant margin coming in. In terms of revenue, it won't make a big impact on the top line because of the sizable commodity business what we have. But in terms of EBITDA margins, they are very healthy.

Darshita Shah
Analyst, DSP Asset Managers

Got it. I have a few questions. I'll get back in the queue.

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

Thank you.

Operator

Thank you. Just a reminder to all the participants to please press star and one on the digital telephone for more questions. The next question is from the line of Somaiah V. from Avendus Spark Private Limited. Please go ahead.

Somaiah V.
Analyst, Avendus Spark Private Limited

Hi, sir. Thanks for the opportunity, sir. My first question is on the industry sale. For first half, what would be the POS complex sales between both NPKs and DAP put together?

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

DAP, NPK is around 104 lakh tons as against last year 121 lakh tons.

Somaiah V.
Analyst, Avendus Spark Private Limited

Understood, sir. Also, we have the split between DAP and NPK.

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

NPK is 60 lakh tons as against last year 77 lakh tons, and DAP is flatish at 44 lakh tons, 44 lakh tons.

Somaiah V.
Analyst, Avendus Spark Private Limited

Sir, that's helpful. Sir, second question is on our granulation facility. You had mentioned about February the start. What is the expectation in the next Kharif? What level of utilization we can get up to? Also in terms of marketing, we have been already going into some of the northern markets and placing the product. What are the expectations in terms of next year of this point and time that will place in the market?

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

See, this year happened to be a very stressful season, and the volumes have contracted in the current year. Always, even with this capacity last year, we had done home lane by importing 8 lakh tons of DAP and NPK fertilizers. I think the new capacity coming in, and hopefully the season won't be this bad like what we witnessed in the current year. We do expect El Niño to turn neutral by year end. I don't see any challenge in operating the plant close to the full capacity, because Coromandel, that has been one of our hallmark, ensuring that all our CapEx get commissioned on time and realize the value on time. We are expanding our retail network.

That will be our main channel to drive part of the volume. We have already started the seed marketing two, three years before in key northern markets like U.P., Rajasthan, and M.P. We will try and improve our volumes going forward into next year as well. I do not see any challenge in ensuring full utilization of the new facility next year. Having said that, we will also be focusing on differentiated product offerings, not to repeat the same generic grades what we have been doing. The facility which is coming up has got capability to have multiple nutrients be added to main NPK products, like boron or zinc.

During the current year, due to the sort of ad hoc policy changes, we could not come up with alternate products. With the way the NBS policy has restored the original design principle of announcing the rates based on the prevailing cost, that is giving us a freedom to reasonably come up with innovation and new products and differentiated product offerings. Our aim would be to see how best we can leverage the new capacity to come up with new products which can add value to the farmers and improve the productivity. That is what we will be focusing. To answer you in short, our target would be to operate the plant at full capacity for the next year.

Somaiah V.
Analyst, Avendus Spark Private Limited

Sir, on the phosphate front, we are near about 70% backward integrated. There is still this 20%-30% headroom. Is this something that we are looking forward or is there any operational challenge? Is the maximum limit that we can get to?

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

First, we want to realize the value of the investment what we have made in Kakinada, operate the plant at full capacity and get the That has been always been our approach. Having invested INR 2,000 crore in setting up the PA-SA plant last year, it is important for us to ramp up the volume and generate the cash out of that investment.

Obviously, we will look forward to additional capacities as and when required. I do not see any challenge in the infrastructure or anything. We have our mining operations also being scaled up at Senegal. I do not see any challenge if we choose to increase the volume. But as a matter of prudence, we will always keep some exposure for bought-out asset. We will not be going in for 100% captive.

Somaiah V.
Analyst, Avendus Spark Private Limited

Understood. Sir, on AgChem, if you could just share the split between exports versus domestic, the mix, and also volume and price impact during the quarter.

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

In terms of exports, I think we have got significant growth this year. Almost 40% of the growth has come from exports, and almost 45% of our revenue has come from exports, which is a very significant number we have got. Thanks to some of our molecules gaining volume in the export market, that was quite helpful.

Somaiah V.
Analyst, Avendus Spark Private Limited

Sir, this mix and growth includes NACL?

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

Sorry?

Somaiah V.
Analyst, Avendus Spark Private Limited

This includes NACL?

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

No, this is Coromandel's CPC segment, and NACL had a setback on exports. I will have to come back to you on the segmental growth of NACL across exports, because we are seeing it as a standalone basis. Coromandel Crop Protection business exports growth has been 44%, and the revenue share has been more than 40%.

Somaiah V.
Analyst, Avendus Spark Private Limited

When you were referring to the opening remark in terms of a product-led challenge at NACL, high-cost inventory, is that been the write-offs or it will kind of normalize now going forward? Any expect that impact to kind of not be there?

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

Obviously, the high-cost inventories have come down, but the input raw material prices we are renegotiating and also looking at the value chain, how do we make those intermediates also in-house. We are trying to optimize the production capacities between the two companies operating plants. Sometime when you operate the plant at low capacity, your efficiency and the conversion cost also goes up. So those issues are being set right and addressed. We are also able to secure some of the raw materials at a competitive price in the current quarter. Hopefully, that should play out now.

See, these sort of challenges in agrochemicals will always be there in terms of sudden compression in margin expansion in next quarter. These things are bound to happen, but the wider portfolio should get smoothened out. We are also trying to see how do we cut down costs, how do we rationalize the field team. So we are working on various initiatives to improve the operational EBITDA, and those things will play out in the coming quarters. See, we need to look at NACL in little more broader sense rather than only studying the EBITDA. NACL is bringing in huge opportunity in terms of spare capacities of active ingredients.

In fact, there may not be any need for Coromandel to invest in active ingredient capacity. We can leverage NACL capacity to a great extent. That is the first advantage. Second is the R&D strength of NACL and Coromandel on a combined basis provide necessary impetus for new-age chemistries like chlorination chemistry. We would not have got into chlorination, put up a launch plant in such a short period of time, but for the talent available in NACL in terms of the R&D team and capability. They have run the pilot plant, and we are able to take it forward and get into this specialty zone, which otherwise would have taken another two years to do.

Access to the spare capacities, access to the chemistry, and the CDMO play in terms of ability to manufacture various intermediates connecting with the global players would be helpful as both the companies work towards having long-term contracts in the CDMO space. I think these are all the things which play out at different point of time, because in the current portfolio of NACL, there is a challenge in the margin and EBITDA, and the molecules are not the new-age molecules.

They are old generic molecules. We are quite aware of the fact when we looked at this target as well. It will take some time because anything to happen in crop protection, it will take two, three years to get the new product registration going. And we have inducted the right set of talents, and we are also working on various new product introductions. I think you all have to give some time for things to play out. May not be measured in terms of the quarterly EBITDA performance in the near future.

Somaiah V.
Analyst, Avendus Spark Private Limited

Understood, sir. One last question from my side. Sir, this fluorination plant that you had mentioned in Ankleshwar. What is the roadmap there? What are the steps in terms of opportunities that potential next few years? What are we expecting the ramp-up in the specialty side? If you could just touch upon that.

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

See, this fluorination, what we are putting up with the launch plant, we have a pilot plant already in place. We are now putting up a launch plant. For any of these fluorination-based chemistries, there are global customers who are keen to tie up with us, but they need samples to be given at all stages of the production, whether it is the R&D stage or a pilot stage or a launch plant stage. So, this is on a commercial scale. We need to give the samples and get tested. And most of these are highly capital-intensive projects, and we don't want to set up the facility unless we have a sign-up with the key customers.

So, we are in the process of identifying those key intermediates which we can sign up with the customers, and once the launch plant is ready with those products and products are cleared, this is a journey which we have embarked one year before and with the NACL getting accelerated now. Once we have a visibility on the product getting cleared with key players, we should be able to set up a commercial plant which may involve CapEx of about INR 200 crore-INR 300 crore, probably one, two years down the line, once we establish the feasibility and viability.

That is what the roadmap we are having, and that can give a good amount of EBITDA margin, completely different from current portfolio. And fluorination-based intermediates are also used in our own captive AIs. So, we are looking at both the opportunities for in-house usage as well as for the CDMO play. I think this will open up the opportunity for us to enter into specialty chemical space, which we have been discussing in the past as well. But we wanted to do slowly. We do not want to commit the CapEx upfront unless we are sure about what we are doing.

Somaiah V.
Analyst, Avendus Spark Private Limited

Sure, sir.

Operator

Thank you. Next question is from the line of Himani from ICICI Prudential Asset Management Limited. Please go ahead.

Himani Badetia
Analyst, ICICI Prudential Asset Management Limited

Hi, sir. Thank you for giving me the opportunity. On the biological side, while you have already highlighted that the growths have come from the biofertilizers being available at the competitive prices versus high-priced NPK, just wanted to understand, should we look at this growth only from this year's phenomena, or is this growth sustainable in future?

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

No, absolutely it is sustainable. Biologicals has got two, three verticals here. One is the neem-based biopesticides, another one is the plant extract, what we have been doing, microbials and plant extract, and third is the organic fertilizers, which are based on industrial waste like press mud as well as municipal waste. Also, we have come up with variants in organic fertilizers by adding other phosphates and nutrients. So, it's a complete bouquet of products, and as a company, we strongly believe in integrated nutrient management, which means 20% of organic and 80% of nutrient chemical fertilizers.

The challenge here is in terms of ensuring the quality products available at the doorstep to the farmers, and the logistics costs are quite high. That is where, when the retail centers coming up in all the remote centers, we are able to service the farming community closer to the place of consumption. The adoption rates are quite high, and this is likely to sustain, and it will grow. There are lot of smaller players with a good researched products available. It need not be a global play. It can be a localized play with lot of micronutrients, microbial addition, and we do our own in-house testing and clear these products.

This is one of the areas which Coromandel will drive through retail outlets to save for environment, save for soil, and save for the farmers, affordable for the farmers as well. So, we are completely bullish on this, and we'll continue to grow on this space. In the biological bioproduct segment, we have made a beginning. We have a lot to catch up on this. In fact, last two quarters, we have been driving these bio verticals through the direct sales, rather than piggyback on the current crop protection channel. We have seen good traction, because most of these bioproducts are concept selling.

It requires a lot of engagement at the farmer level, right from the crop development to until the fruiting stage. So, I think this is the way to go, and we have got a few product pipelines. Currently, the share of bioproducts is relatively less. Our aim is to see how best we can scale up in the non-subsidy segment and be a significant play. The EBITDA margins are completely different. We have seen the traction here, and we will continue to build on this. It is not a one-off thing. It will sustain and it will build and grow on this.

Himani Badetia
Analyst, ICICI Prudential Asset Management Limited

Understood, sir. Thank you so much.

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

Thank you.

Operator

Thank you. The next question is from the line of Archit Joshi from Nuvama Wealth Limited. Please go ahead.

Archit Joshi
Analyst, Nuvama Wealth Limited

Hi. Good morning, sir, and Deepavali greetings to the entire team. Sir, just one question. We had shared something on the battery-grade phosphoric acid in the last two interactions. Any developments there in terms of technology or any long-term partnerships, any CapEx, any economics that you can help us with on that account? Thank you.

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

Too much preoccupied with the nutrient, our mind space was not there on this. They have taken a backseat. We are working on it. Technology is available. Here again, we need to ensure that we have a customer stickiness. We need to work along with some of the few end consumers of this battery-grade acid. We will evaluate again back, and there has been slowdown on this the last two, three quarters because of the challenges and the headwinds we faced in the main business. Hopefully, we should come back to it in the fourth quarter. I have nothing much to share at this point of time.

Archit Joshi
Analyst, Nuvama Wealth Limited

Sure, sir. No problem. Thank you. Thanks a lot. That is it from me.

Operator

Thank you. The next question is from the line of Abhijit Akella from Kotak Securities Private Limited. Please go ahead.

Abhijit Akella
Analyst, Kotak Securities Private Limited

Yeah. Good morning, sir. Thank you so much for taking my questions.

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

Good morning.

Abhijit Akella
Analyst, Kotak Securities Private Limited

Good morning. First one was just now that the Rabi subsidy rates are known for the second half. Would we have sort of a fairer idea of where we could expect EBITDA per ton to settle at for FY 2027?

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

Too early to count the chickens. Let's wait for the quarter to close because things are so volatile. The last two quarters have completely destabilized in terms of margin structures. I would prefer to wait, but things have improved significantly. Our value addition is restored now. The challenge here is not the margin per se, but it is more of a volume. How do we revive the consumption? To what extent we need to set the market price? These things will play out in coming weeks.

Probably one more quarter we should be able to give you precise, but structurally, directionally, we are there. Even in this stressful quarter, we have done a decent number in Q2 in terms of both manufactured margin and some opportunistic imports, which has helped us to have a decent margin on imports as NPKs as well. I think we should be able to come closer to what we have been talking about in the past from Q3 onwards. Until the consumption revives, I do not want to do any second-guessing at this point of time, but things are looking positive.

Abhijit Akella
Analyst, Kotak Securities Private Limited

Sure, understood. The second one was just on the subsidy announcement itself. In your reading, does it seem somewhat more favorable towards the NPK segment rather than towards DAP? That was one question. The other one is that, footnote five of the financial results we have disclosed says that the necessary consequential impact of this NBS announcement will be taken in the subsequent quarter. Is there any adjustment required to be already declared Kharif season results also, or this will only be with prospective effect?

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

There can be some positive impact on the channel inventory what industry is carrying because these subsidies are paid out on POS basis consumption. There will be a positive impact on the high-cost carryover inventory, but it will neutralize the high cost. Otherwise, it would have been a loss for the industry. Rather than saying whether there is a positive impact, I think industry will not have negative impact going forward, I would say, because we had to be rightfully compensated for having purchased and produced and carrying the high-cost inventory.

That will be reasonably compensated as we sell these fertilizers to the end consumers, farmers. To that extent, there will be a positive impact in the coming quarter. Second, in terms of shift favoring NPK, ideally, it will always should be that way only. NPK is a balanced nutrition, and domestic sector is focused on NP and PK fertilizers, and we can make it available during these challenging times. DAP capping at INR 1,350 is an aberration.

I think now we have come back to normalcy, and this is the way to go. I do feel that NP and PK consumption should come back. At some stage, even this capping of DAP may get released because government also cannot afford that sort of a higher subsidy, and let the farmer decide which fertilizer he has to use. That is the right thing to do, and that is what this industry also we have been advocating.

Abhijit Akella
Analyst, Kotak Securities Private Limited

Okay, sir. Just last two quick ones from my side. One is the Framework for Fertilizer Sale. Does that apply only to Urea and DAP or also to NPKs? If it is the latter, then is there some impact on possible volume growth in the NPK category also from here?

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

It is applicable for all, but I do not know. There have been some areas where ideally some of the cash crop farmers need higher volumes of NP and PKs, which they are not currently able to do because of this restriction. Industry has already started engaging with the government and given this feedback to ensure that the farmer who needs the right dosage of NP and PK should not be deprived on this. Package of practices developed by agriculture universities need to be updated, and we have already written to the government.

We will be engaging with them. It is very important that right dosages, latest new innovative products are factored in the package of practices before they put out this system. This is on a pilot scale. The feedbacks have been given. We will take it up further with the government to see that it does not adversely impact the availability of these fertilizers to farmers who are in need of them. It is a serious concern which we are trying to address.

Abhijit Akella
Analyst, Kotak Securities Private Limited

Perfect, sir. The last one was on the fluorination plant side. In the last two, three years, we have seen quite a lot of Chinese capacity coming up in the fluorine derivative space, and some of the larger Indian companies have also been undergoing some struggles in that space. In that backdrop, how do we plan to differentiate whatever offerings you plan to put up over here?

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

One or two things. First, we are trying to establish the proof of concept and looking at fluorination chemistry-based agrochemical intermediates and certain pharma intermediates. Right now, we are not creating complete downstream. But one unique advantage Coromandel has got is in terms of hydrofluorosilicic acid, which helps us to diversify into fluorination chemistry rather than using fluorspar route. So, while China is competing on the fluorspar route, our ability to leverage on our byproduct, which is coming from our phosphoric acid, can be a good value addition.

So, that can provide the complete value chain in the fluorination chemistry space. So, our unique advantage of our own captive raw material can give us competitive advantage compared to others. But having said that, we need to establish the market and identify partners who will off-take the volumes. These capacities will come up based on the market needs rather than looking for the market after the capacity comes in. So, we will have lock-in customers before we move ahead with the CapEx.

Abhijit Akella
Analyst, Kotak Securities Private Limited

Got it, sir. Thank you so much and wish you all the best.

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

Thank you.

Operator

Thank you. The next question is from the line of Bharat Sheth from Quest Investment Advisors Private Limited. Please go ahead.

Bharat Sheth
Analyst, Quest Investment Advisors Private Limited

Hi, sir. Thanks for the opportunity. Sir, all my questions are, but can you give a little more color on this non-subsidy and non-agrochemical business? The size of the business and how do where we are talking of very bullish, so how difficult is to scalable, I mean, and what are kind of entry barrier that it has so people cannot enter into?

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

See, agrochemicals at least you are familiar, so there's a complete landscape known to everyone. In terms of bio products, all the products are unique and specific to Coromandel, whether it is neem-based biopesticides or microbials. These are all in-house research product. And even these biofertilizers, some of them are specifically registered and developed by us in-house. I think to that extent, it has a strong entry barrier. But scaling up of volumes would be a challenge because they are applied in low dosage and it conceptually takes time to develop the market. So it's a combination of product uniqueness and the product branding and reach is important.

And in the global markets, the registration presence there is important where with our wider portfolio of crop protection, nano, bio, we are much better placed with agrochemical business in 80- 90 countries. It makes us easily accessible to these markets for cross-selling these products, whether it is nano or bio products. To that extent, we are rightfully positioned to scale up the volumes. On the specialties, of course, it's a larger play, lot of competitors are there, lot of global players are there, and we depend on imported raw materials. And here again, we are trying to invest on our own captive MAP. There are a lot of key raw materials are imported from China.

We are trying to reduce the Chinese dependence, and we are putting up our own MAP plant, which will feed into our own WSF manufacturing. So here again, our uniqueness of coming up with the crop-based water-soluble grades, bringing in differentiation from rest makes an important, and our significant market presence in key markets, agriculture markets, and our presence over the last two, three decades in specialty nutrients have put us in a very strong pedestal compared to the rest of the players. We are having a sustainable volume growth of 20%, 25%. Even during this stressful period, we are able to manage this.

Other advantage we have is our large sourcing capability in fertilizer can have a positive rub-off effect in these businesses where the similar type of raw materials are being sourced. So our sourcing efficiency, our infrastructure, our dispatch supply chain through our common rakes of fertilizers, all these are something unique to Coromandel, may be difficult for the rest of the players to compete in the market space. We do not compete on generic play, we focus on specialties. To that extent, we have less competition intensity.

Bharat Sheth
Analyst, Quest Investment Advisors Private Limited

What is the current annual size of the business and how do we look at scaling up growth over next two, three years?

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

Which business?

Bharat Sheth
Analyst, Quest Investment Advisors Private Limited

Yeah, this business, I mean, all bio and non-agri, non-subsidy and non-AgChem.

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

Probably it is not differentiated as a separate segment. I am not sure this quarter whether you can put out those numbers. Probably I will get back to you, but they are gathering momentum. They are very significant and they have reached the size and scale comparable to the individual listed entities as well, especially on specialty nutrients and bio products, a significant play.

Bharat Sheth
Analyst, Quest Investment Advisors Private Limited

Last question, sir, any update on the Dhaksha?

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

Waiting for good days. Next quarter definitely I should be able to give you good news in the defense order.

Bharat Sheth
Analyst, Quest Investment Advisors Private Limited

Hopefully, you know

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

few good things have happened in the last quarter on Dhaksha. We have introduced two new variants in agri drones. We have scaled up our volumes of agri operations in Coromandel through Dhaksha drones. We have done sizable volumes through retail outlets, and we have seen wherever we are using drone spraying, our volume of liquid fertilizers and liquid agrochemicals have gone up significantly. Now we are attaching agri drones to each of our retail centers, and there are pilots attached to each of the retail centers, and they will be executing this agri drone services. I am very reasonably confident that future agri revolution in India will happen through drone spraying.

Right now it is confined to spraying, but it can move into precision agriculture at a later stage. This is as far as agri vertical is concerned. On the defense side and the surveillance drones and other fixed-wing drones, we are already working on. We have come up with two, three new variants, and we are going in for registration with defense. Hopefully, once we get the order cleared for the earlier order, we should be able to make complete offerings. Some of the demonstrations we have given on these drones at the very high altitude in Kargil sector was very well received by Army, and hopefully we should be able to get the orders.

This sector is growing at the annual CAGR of 25%, and not many established players are there. We have created a large ecosystem with a facility for 130,000 sq ft, trying to develop indigenous vendors. We are looking to partner with other institutions to get the access to latest technologies. We have worked much on the product offerings, range, everything. It will take some time. Once we are able to execute the order, we should be able to realize the value out of this Dhaksha. I know it is completely different from agri inputs, but being part of this on agriculture side, drones have been helpful. On the defense side, it opens up the new opportunity.

Bharat Sheth
Analyst, Quest Investment Advisors Private Limited

Thank you and all the best, sir.

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

Thank you.

Operator

Thank you. As there are no further questions from the participants, I now hand the conference over to Mr. S. Sankarasubramanian for closing comments.

S. Sankarasubramanian
Managing Director and CEO, Coromandel International

I think looking ahead, we are cautiously optimistic about the Rabi season. Supported by improved fundamentals and commodity prices have started showing signs of moderation. The recent revision in MSP rates also should be more supportive for fertilizer sector. The demand side farm economics remain broadly supportive. Agri commodity prices of key crops are holding above MSP level, and that should support farm cash flows and input affordability as we move to the Rabi season.

We are also seeing some improvement in agriculture environment. The recent rainfall has been quite helpful in replenishing the soil moisture in the country, and sowing has begun to pick up now, although aggregate acreage remains behind last year at this stage. Thank you for your insightful inputs and questions, and hope to see you again next quarter. Thank you very much.

Operator

Thank you. On behalf of Systematix Shares and Stocks Limited, that concludes this conference. Thank you for joining us, and you may now disconnect your lines.